Trilinolein is an orally active triglyceride that inhibits the PI3K/Akt, Ras/MEK/ERK signaling pathways, and MMP-2. It can reduce oxidative stress, induce apoptosis, and inhibit cell migration. Trilinolein can be used in the research fields of cardiovascular disease, cerebrovascular disease (such as cerebral ischemia), and non-small cell lung cancer.
- Inhibits PI3K/Akt, Ras/MEK/ERK signaling pathways, and MMP-2.
- Reduces oxidative stress.
- Induces apoptosis.
- Inhibits cell migration.
- Useful for research in cardiovascular disease.
- Useful for research in cerebrovascular disease, such as cerebral ischemia.
- Useful for research in non-small cell lung cancer.